Content about Buddhism

February 21, 2013
Valeant buys rights to Eisai's Targretin

Valeant Pharmaceuticals has bought rights to a drug used to treat skin cancer from Eisai, the companies said Thursday.

July 29, 2011
FDA to Eisai: Redo application for perampanel

The Food and Drug Administration has asked Eisai to redo its regulatory application for a drug to treat epilepsy, Eisai said Friday.

March 4, 2011
Eisai's Banzel OKed as epilepsy treatment

The Food and Drug Administration has approved a drug made by Eisai to treat a rare form of epilepsy, the drug maker said Friday.

© 2013 Drug Store News. All Rights Reserved.